Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative): British Journal of Dermatology

Autor: Chalmers, J. R., Simpson, E., Apfelbacher, C. J., Thomas, S.K., von Kobyletzki, L., Schmitt, J., Singh, J.A., Svensson, A., Williams, H.C., Abuabara, K., Aoki, V., Ardeleanu, M., Awici-Rasmussen, M., Barbarot, S., Berents, T. L., Block, J., Bragg, A., Burton, T., Clemmensen, K. K. B., Creswell-Melville, A., Dinesen, M., Drucker, A., Eckert, R.L., Flohr, C., Garg, M., Gerbens, L. A. A., Graff, A. L. B., Hanifin, J., Heinl, D., Humphreys, R., Ishii, H.A., Kataoka, Y., Leshem, Y. A., Marquort, B., Massuel, M. A., Merhand, S., Mizutani, H., Murota, H., Murrell, D.F., Nakahara, T., Nasr, I., Nograles, K., Ohya, Y., Osterloh, I., Pander, J., Prinsen, C., Purkins, L., Ridd, M.J., Sach, T., Schuttelaar, M. L. A., Shindo, S., Smirnova, J., Sulzer, A., Gjerde, E. S., Takaoka, R., Talmo, H. V., Tauber, M., Torchet, F., Volke, A., Wahlgren, C.F., Weidinger, S., Weisshaar, E., Wollenberg, A., Yamaga, K., Zhao, C. Y., Spuls, P.I.

Publikováno v: British Journal of Dermatology, 175, 69-79. Wiley-Blackwell
Chalmers, J R, Simpson, E, Apfelbacher, C J, Thomas, S K, von Kobyletzki, L, Schmitt, J, Singh, J A, Svensson, A, Williams, H C, Abuabara, K, Aoki, V, Ardeleanu, M, Awici-Rasmussen, M, Barbarot, S, Berents, T L, Block, J, Bragg, A, Burton, T, Clemmensen, K K B, Creswell-Melville, A, Dinesen, M, Drucker, A, Eckert, R L, Flohr, C, Garg, M, Gerbens, L A A, Graff, A L B, Hanifin, J, Heinl, D, Humphreys, R, Ishii, H A, Kataoka, Y, Leshem, Y A, Marquort, B, Massuel, M A, Merhand, S, Mizutani, H, Murota, H, Murrell, D F, Nakahara, T, Nasr, I, Nograles, K, Ohya, Y, Osterloh, I, Pander, J, Prinsen, C, Purkins, L, Ridd, M J, Sach, T, Schuttelaar, M L A, Shindo, S, Smirnova, J, Sulzer, A, Gjerde, E S, Takaoka, R, Talmo, H V, Tauber, M, Torchet, F, Volke, A, Wahlgren, C F, Weidinger, S, Weisshaar, E, Wollenberg, A, Yamaga, K, Zhao, C Y & Spuls, P I 2016, ' Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative) : British Journal of Dermatology ', British Journal of Dermatology, vol. 175, pp. 69-79 . https://doi.org/10.1111/bjd.14773

This article is a report of the fourth meeting of the Harmonising Outcome Measures for Eczema (HOME) initiative held in Malmo, Sweden on 23-24 April 2015 (HOME IV). The aim of the meeting was to achieve consensus over the preferred outcome instrument

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::3d3d02a9e6cda5a3ca1a4de032e5fce8
https://research.vumc.nl/en/publications/ead727c0-92a8-4f13-8d54-912d5485e75f

Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative).

Autor: Chalmers JR; Centre of Evidence Based Dermatology, University of Nottingham, Nottingham, U.K., Simpson E; Department of Dermatology, Oregon Health and Science University, Portland, OR, U.S.A., Apfelbacher CJ; Medical Sociology, Institute of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany., Thomas KS; Centre of Evidence Based Dermatology, University of Nottingham, Nottingham, U.K., von Kobyletzki L; Lund University, Skåne University Hospital, Department of Dermatology, Malmö, Sweden.; Department of Public Health Sciences, Karlstad University, Karlstad, Sweden., Schmitt J; Centre for Evidence-Based Healthcare, University of Dresden, Dresden, Germany.; Department of Occupational and Social Medicine, Technical University Dresden, Dresden, Germany., Singh JA; Medicine Service, Birmingham VA Medical Center, Birmingham, AL, U.S.A.; Department of Medicine, University of Alabama, Birmingham, AL, U.S.A., Svensson Å; Department of Dermatology and Venereology, Malmö University Hospital, Malmö, Sweden., Williams HC; Centre of Evidence Based Dermatology, University of Nottingham, Nottingham, U.K., Abuabara K; Department of Dermatology, University of California San Francisco, San Francisco, California, CA, U.S.A., Aoki V; Department of Dermatology, University of São Paulo Medical School, São Paulo, Brazil., Ardeleanu M; Immunology and Inflammation, Regeneron Pharmaceuticals, Inc., New York, NY, U.S.A., Awici-Rasmussen M; Psoriasis and Eczema Association of Norway, Oslo, Norway., Barbarot S; Department of Dermatology, CHU de Nantes, Nantes, France., Berents TL; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Dermatology, Oslo University Hospital, Oslo, Norway., Block J; National Eczema Organisation, National Eczema Association, San Rafael, CA, U.S.A., Bragg A; Chugai Pharma Europe Ltd., London, U.K., Burton T; No affiliation (patient representative U.K.)., Bjerring Clemmensen KK; Department of Dermatology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark., Creswell-Melville A; Société Canadienne de l'Eczéma, Keswick, ON, Canada., Dinesen M; LEO Pharma A/S, Industriparken 55, Ballerup, Denmark., Drucker A; Division of Dermatology, University Health Network, Toronto, ON, Canada., Eckert L; Health Economics and Outcomes Research, Sanofi, France., Flohr C; St John's Institute of Dermatology, Guy's and St Thomas' Hospitals NHS Foundation Trust and King's College London, London, U.K., Garg M; LEO Pharma, Copenhagen, Denmark., Gerbens LA; Department of Dermatology, Academic Medical Centre, University of Amsterdam, Amsterdam, the Netherlands., Graff AL; National Eczema Society, London, U.K., Hanifin J; Department of Dermatology, Oregon Health and Science University, Portland, OR, U.S.A., Heinl D; Medical Sociology, Institute of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany., Humphreys R; National Eczema Society, London, U.K., Ishii HA; Brazilian Atopic Dermatitis Association (AADA), São Paulo, Brazil., Kataoka Y; Osaka Prefectural Medical Center for Respiratory and Allergic Disease, Osaka, Japan., Leshem YA; Department of Dermatology, Oregon Health and Science University, Portland, OR, U.S.A., Marquort B; No affiliation (patient representative Sweden)., Massuel MA; Sanofi-Aventis, Paris, France., Merhand S; Association Française de l'Eczéma, Redon, France., Mizutani H; Mie University, Graduate School of Medicine and Mie University Hospital Tsu, Mie, Japan., Murota H; Department of Dermatology, Osaka University, Osaka, Japan., Murrell DF; Department of Dermatology, St George Hospital, Sydney, Australia.; University of New South Wales, Sydney, Australia., Nakahara T; Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan., Nasr I; Retired, no affiliation., Nograles K; Celgene Corporation, Greater New York City Area Pharmaceuticals, New York, NY, U.S.A., Ohya Y; Division of Allergy, Department of Medical Subspecialties, National Center for Child Health and Development, Tokyo, Japan., Osterloh I; Ostermed Ltd., Kent, U.K., Pander J; Celgene BV, Utrecht, the Netherlands., Prinsen C; Department of Epidemiology and Biostatistics, EMGO+ Institute for Health and Care Research, VU University Medical Centre, Amsterdam, the Netherlands., Purkins L; Ziarco Pharma Ltd, Kent, U.K., Ridd M; School of Social & Community Medicine, University of Bristol, Bristol, U.K., Sach T; Health Economics Group, University of East Anglia, Norwich, U.K., Schuttelaar ML; Department of Dermatology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Shindo S; Department of Dermatology, Osaka University, Osaka, Japan., Smirnova J; Department of Public Health Sciences, Karlstad University, Karlstad, Sweden., Sulzer A; Sanofi-Aventis, Montpellier, France., Synnøve Gjerde E; Psoriasis and Eczema Association of Norway, Oslo, Norway., Takaoka R; Department of Dermatology, University of São Paulo Medical School, São Paulo, Brazil., Vestby Talmo H; Sanofi-Aventis, Montpellier, France., Tauber M; Toulouse University, Toulouse, France., Torchet F; Mie University, Graduate School of Medicine and Mie University Hospital Tsu, Mie, Japan., Volke A; Department of Dermatology, University of Tartu, Tartu, Estonia., Wahlgren CF; Dermatology Unit, Department of Medicine, Karolinska Institutet, Solna, Sweden.; Karolinska University Hospital, Stockholm, Sweden., Weidinger S; Department of Dermatology, Venereology and Allergy University Hospital Schleswig-Holstein, Kiel, Germany., Weisshaar E; Occupational and Environmental Dermatology, Department of Social Medicine, University of Heidelberg, Heidelberg, Germany., Wollenberg A; Department of Dermatology and Allergy, Ludwig-Maximilian University, Munich, Germany., Yamaga K; Department of Dermatology, Osaka University, Osaka, Japan., Zhao CY; Department of Dermatology, St George Hospital, Sydney, Australia.; University of New South Wales, Sydney, Australia., Spuls PI; Department of Dermatology, Academic Medical Centre, University of Amsterdam, Amsterdam, the Netherlands.

Publikováno v: The British journal of dermatology [Br J Dermatol] 2016 Jul; Vol. 175 (1), pp. 69-79. Date of Electronic Publication: 2016 Jul 19.